In canine tumors, alterations in PTEN protein expression have been demonstrated in melanoma [24], hemangiosarcoma [25], osteosarcoma [26,27], prostatic carcinomas [28], and mammary tumors [29,30,31,32]. This evidence concerns the gene PTEN and angiosarcoma.